The extension follows a tumultuous time for the Gaithersburg company, making it unclear if the government would proceed with deals as normal.
{iframe}https://www.bizjournals.com/baltimore/news/2021/07/21/emergent-biolsolutions-wins-smallpox-vaccine-deal.html{/iframe}